Chloroquine-Induced First-Episode Psychosis in a Patient Self-medicated for COVID-19.

Szczegóły

Tytuł:: Chloroquine-Induced First-Episode Psychosis in a Patient Self-medicated for COVID-19.
Autorzy:: Ambar Akkaoui M; Department of Psychiatry and Addictive Medicine, Hôpital Bichat-Claude-Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France. Electronic address: .
Lejoyeux M; Department of Psychiatry and Addictive Medicine, Hôpital Bichat-Claude-Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris, Paris, France.
Geoffroy PA; Department of Psychiatry and Addictive Medicine, Hôpital Bichat-Claude-Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France; Joint Research Unit 1141, Université de Paris, NeuroDiderot, Inserm, F-75019. Paris, France.
Źródło:: Biological psychiatry [Biol Psychiatry] 2021 Feb 01; Vol. 89 (3), pp. e9. Date of Electronic Publication: 2020 Jun 02.
Typ publikacji:: Case Reports; Letter
Język:: English
Imprint Name(s):: Publication: New York, NY : Elsevier
Original Publication: New York, Plenum Pub. Corp.
MeSH Terms:: Antiviral Agents*/adverse effects
Chloroquine*/adverse effects
Psychoses, Substance-Induced*
COVID-19 Drug Treatment*
Humans ; SARS-CoV-2
References:: Clin Case Rep. 2015 Jun;3(6):379-87. (PMID: 26185633)
Gen Hosp Psychiatry. 2014 Mar-Apr;36(2):181-6. (PMID: 24290896)
JAMA Netw Open. 2020 Apr 24;3(4):e209035. (PMID: 32330276)
J Crit Care. 2020 Jun;57:279-283. (PMID: 32173110)
Int J Antimicrob Agents. 2020 Jul;56(1):105949. (PMID: 32205204)
Substance Nomenclature:: 0 (Antiviral Agents)
886U3H6UFF (Chloroquine)
Entry Date(s):: Date Created: 20200620 Date Completed: 20210106 Latest Revision: 20221207
Update Code:: 20240105
PubMed Central ID:: PMC7265830
DOI:: 10.1016/j.biopsych.2020.05.032
PMID:: 32553277
: Raport

Full Text Finder

Informacja